KHK and hepatocellular carcinoma: Lin et al. found that splicing variations of KHK are associated with the survival and recurrence of HCC patients and are linked to mutations in TP53 and ARID1A, suggesting that these alterations in KHK may promote tumor progression by regulating key signaling pathways 157.